drug · vaccine component
rotavirus [serotypes G1, G2, G3, G4, G9] (pentavalent) vaccine
pre_registrationupdated 3mo agoby $GSK GSK plc🔗 ChEMBL
community read0 votes
Vaccine component drug with a maximum clinical stage of Approval (across all indications), with an approval for rotavirus infection and 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
Trials studying rotavirus [serotypes G1, G2, G3, G4, G9] (pentavalent) vaccine
- phase3Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
- phase3Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
- phase3Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants
- phase3Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that